2.48
price up icon5.08%   0.12
pre-market  Pre-mercato:  2.28   -0.20   -8.06%
loading

Phio Pharmaceuticals Corp Azioni (PHIO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 0.231 - -
Operating Expenses
23.34%
2.309
1.872 1.674 1.59 1.914
Operating Income/Loss
23.34%
-2.309
-1.872 -1.674 -1.59 -1.914
Nonoperating Income/Loss
750.00%
0.143
-0.022 - 0.066 0.068
Income/Loss From Continuing Operations Before Tax
22.44%
-2.166
-1.769 5.755 -1.524 -1.846
Income/Loss From Continuing Operations After Tax
22.44%
-2.166
-1.769 -1.626 -1.524 -1.846
Net Income/Loss
22.44%
-2.166
-1.769 -1.626 -1.524 -1.846
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11.32%
4.7949
4.3073 0.1166 0.99 0.5102
Diluted Average Shares
11.32%
4.7949
4.3073 0.1166 0.99 0.5102
Basic Earnings Per Share
9.76%
-0.45
-0.41 -0.85 -1.54 -3.62
Diluted Earnings Per Share
9.76%
-0.45
-0.41 -0.85 -1.54 -3.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Capitalizzazione:     |  Volume (24 ore):